Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Gross Profit (2021 - 2022)

Historic Gross Profit for SELLAS Life Sciences (SLS) over the last 3 years, with Q1 2022 value amounting to $900000.0.

  • SELLAS Life Sciences' Gross Profit fell 8392.86% to $900000.0 in Q1 2022 from the same period last year, while for Dec 2022 it was $900000.0, marking a year-over-year decrease of 8783.78%. This contributed to the annual value of $900000.0 for FY2022, which is 8783.78% down from last year.
  • SELLAS Life Sciences' Gross Profit amounted to $900000.0 in Q1 2022, which was down 8392.86% from $1.8 million recorded in Q2 2021.
  • SELLAS Life Sciences' Gross Profit's 5-year high stood at $5.6 million during Q1 2021, with a 5-year trough of $900000.0 in Q1 2022.
  • Its 3-year average for Gross Profit is $2.6 million, with a median of $1.8 million in 2020.
  • Within the past 5 years, the most significant YoY rise in SELLAS Life Sciences' Gross Profit was 8392.86% (2022), while the steepest drop was 8392.86% (2022).
  • SELLAS Life Sciences' Gross Profit (Quarter) stood at $1.9 million in 2020, then dropped by 5.26% to $1.8 million in 2021, then tumbled by 50.0% to $900000.0 in 2022.
  • Its Gross Profit was $900000.0 in Q1 2022, compared to $1.8 million in Q2 2021 and $5.6 million in Q1 2021.